

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 7.27304701 |
| 2 | DNA deamination (GO:0045006) | 6.62427123 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 6.12723217 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.75203272 |
| 5 | viral transcription (GO:0019083) | 5.57800850 |
| 6 | cytidine deamination (GO:0009972) | 5.37125536 |
| 7 | cytidine metabolic process (GO:0046087) | 5.37125536 |
| 8 | cytidine catabolic process (GO:0006216) | 5.37125536 |
| 9 | translational termination (GO:0006415) | 5.32635698 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.01718646 |
| 11 | ATP synthesis coupled proton transport (GO:0015986) | 5.01718646 |
| 12 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.99010334 |
| 13 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.91296009 |
| 14 | translational elongation (GO:0006414) | 4.90025255 |
| 15 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.79291669 |
| 16 | maturation of SSU-rRNA (GO:0030490) | 4.74229412 |
| 17 | cotranslational protein targeting to membrane (GO:0006613) | 4.68392490 |
| 18 | protein targeting to ER (GO:0045047) | 4.65139981 |
| 19 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.54091197 |
| 20 | protein localization to endoplasmic reticulum (GO:0070972) | 4.43844817 |
| 21 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.43262450 |
| 22 | respiratory electron transport chain (GO:0022904) | 4.28210040 |
| 23 | electron transport chain (GO:0022900) | 4.23210725 |
| 24 | ribosomal large subunit biogenesis (GO:0042273) | 4.09118987 |
| 25 | cellular protein complex disassembly (GO:0043624) | 4.04797345 |
| 26 | viral life cycle (GO:0019058) | 3.99638114 |
| 27 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.96188995 |
| 28 | ncRNA 3-end processing (GO:0043628) | 3.87024931 |
| 29 | protein complex biogenesis (GO:0070271) | 3.86027007 |
| 30 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.81008409 |
| 31 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.66935984 |
| 32 | translational initiation (GO:0006413) | 3.64386416 |
| 33 | base-excision repair, AP site formation (GO:0006285) | 3.54160249 |
| 34 | chaperone-mediated protein transport (GO:0072321) | 3.54020117 |
| 35 | protein neddylation (GO:0045116) | 3.53778357 |
| 36 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.51240730 |
| 37 | negative regulation of T cell apoptotic process (GO:0070233) | 3.49993187 |
| 38 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.48285956 |
| 39 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.48285956 |
| 40 | NADH dehydrogenase complex assembly (GO:0010257) | 3.48285956 |
| 41 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.47064712 |
| 42 | deoxyribonucleotide catabolic process (GO:0009264) | 3.46991144 |
| 43 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.45448398 |
| 44 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.42311423 |
| 45 | regulation of regulatory T cell differentiation (GO:0045589) | 3.41295323 |
| 46 | translation (GO:0006412) | 3.39798715 |
| 47 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.37907107 |
| 48 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.36691166 |
| 49 | protein complex disassembly (GO:0043241) | 3.30189490 |
| 50 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.28923149 |
| 51 | sequestering of actin monomers (GO:0042989) | 3.24756569 |
| 52 | deoxyribose phosphate catabolic process (GO:0046386) | 3.24610416 |
| 53 | cellular component biogenesis (GO:0044085) | 3.21024150 |
| 54 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.19588234 |
| 55 | macromolecular complex disassembly (GO:0032984) | 3.12327666 |
| 56 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.12130280 |
| 57 | actin nucleation (GO:0045010) | 3.11614022 |
| 58 | positive T cell selection (GO:0043368) | 3.08611163 |
| 59 | platelet dense granule organization (GO:0060155) | 3.07604527 |
| 60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.03141138 |
| 61 | positive thymic T cell selection (GO:0045059) | 3.00408236 |
| 62 | protein targeting to membrane (GO:0006612) | 2.97285531 |
| 63 | metallo-sulfur cluster assembly (GO:0031163) | 2.97199372 |
| 64 | iron-sulfur cluster assembly (GO:0016226) | 2.97199372 |
| 65 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.93464201 |
| 66 | termination of RNA polymerase III transcription (GO:0006386) | 2.93464201 |
| 67 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.88465672 |
| 68 | hydrogen ion transmembrane transport (GO:1902600) | 2.87829152 |
| 69 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.85787428 |
| 70 | ATP biosynthetic process (GO:0006754) | 2.84946932 |
| 71 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.78132475 |
| 72 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.77967640 |
| 73 | purine nucleotide salvage (GO:0032261) | 2.75571775 |
| 74 | purine-containing compound salvage (GO:0043101) | 2.74037461 |
| 75 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.72547763 |
| 76 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.71672884 |
| 77 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.70347246 |
| 78 | proton transport (GO:0015992) | 2.69822367 |
| 79 | mRNA catabolic process (GO:0006402) | 2.69503134 |
| 80 | pseudouridine synthesis (GO:0001522) | 2.68699848 |
| 81 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.68071477 |
| 82 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.66549313 |
| 83 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.66375251 |
| 84 | hydrogen transport (GO:0006818) | 2.64747062 |
| 85 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.62886532 |
| 86 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.61601344 |
| 87 | regulation of T cell apoptotic process (GO:0070232) | 2.60827821 |
| 88 | positive regulation of defense response to virus by host (GO:0002230) | 2.60408794 |
| 89 | cytochrome complex assembly (GO:0017004) | 2.59633998 |
| 90 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.57201077 |
| 91 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.56437691 |
| 92 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.56437691 |
| 93 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.56437691 |
| 94 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.56047114 |
| 95 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.56047114 |
| 96 | negative T cell selection (GO:0043383) | 2.55347911 |
| 97 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.54732775 |
| 98 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.54732775 |
| 99 | behavioral response to nicotine (GO:0035095) | 2.54664973 |
| 100 | respiratory chain complex IV assembly (GO:0008535) | 2.54019089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.25011005 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.92705348 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.71907336 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.36606710 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.05318041 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.99622992 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.77235561 |
| 8 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.73571853 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.70349050 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.69128273 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.60903920 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.52111986 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.49734639 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.42011586 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.37345083 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.35883987 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.32581562 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.29720887 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.00696009 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.84779118 |
| 21 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.82032167 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.81392608 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.77855481 |
| 24 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.67265059 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.65230583 |
| 26 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.63476219 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56511955 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.56180159 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54622574 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.54190740 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52074349 |
| 32 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.49371945 |
| 33 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.47922657 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.47422938 |
| 35 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.46651946 |
| 36 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.45771710 |
| 37 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.44531586 |
| 38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.42471532 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40154613 |
| 40 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.39658388 |
| 41 | AR_20517297_ChIP-Seq_VCAP_Human | 1.34901715 |
| 42 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.34342455 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.34177983 |
| 44 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.33242631 |
| 45 | MYB_26560356_Chip-Seq_TH2_Human | 1.33041382 |
| 46 | EWS_26573619_Chip-Seq_HEK293_Human | 1.32273185 |
| 47 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32073094 |
| 48 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31733923 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31316892 |
| 50 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.31159116 |
| 51 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.26643977 |
| 52 | NCOR_22424771_ChIP-Seq_293T_Human | 1.25626944 |
| 53 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25567936 |
| 54 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.25166094 |
| 55 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.25166094 |
| 56 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.24690244 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24670678 |
| 58 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.22867668 |
| 59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22015794 |
| 60 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20621998 |
| 61 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.19381883 |
| 62 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.14784664 |
| 63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.13667741 |
| 64 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12808835 |
| 65 | ERA_21632823_ChIP-Seq_H3396_Human | 1.11274529 |
| 66 | P300_27268052_Chip-Seq_Bcells_Human | 1.10304130 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08779910 |
| 68 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.08117468 |
| 69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07370512 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06748746 |
| 71 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06295347 |
| 72 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05412652 |
| 73 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04524907 |
| 74 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.04489325 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.03263158 |
| 76 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.03028090 |
| 77 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.02815109 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02307036 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01838763 |
| 80 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.01627801 |
| 81 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00873377 |
| 82 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.98907060 |
| 83 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98900232 |
| 84 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.98609329 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98503140 |
| 86 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.98366233 |
| 87 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.98363964 |
| 88 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98136286 |
| 89 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97229553 |
| 90 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97229553 |
| 91 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.96573359 |
| 92 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95868571 |
| 93 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95491343 |
| 94 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.94661132 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.93697711 |
| 96 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93575835 |
| 97 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92785212 |
| 98 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.91637948 |
| 99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91283925 |
| 100 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.91245065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.59896988 |
| 2 | MP0009379_abnormal_foot_pigmentation | 4.52212460 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.92567544 |
| 4 | MP0006292_abnormal_olfactory_placode | 2.77886499 |
| 5 | MP0009785_altered_susceptibility_to | 2.46924835 |
| 6 | MP0001873_stomach_inflammation | 2.29224216 |
| 7 | MP0005646_abnormal_pituitary_gland | 2.11781833 |
| 8 | MP0003646_muscle_fatigue | 2.06739144 |
| 9 | MP0005645_abnormal_hypothalamus_physiol | 1.97484968 |
| 10 | MP0002163_abnormal_gland_morphology | 1.97013332 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 1.86839731 |
| 12 | MP0003763_abnormal_thymus_physiology | 1.79462103 |
| 13 | MP0001800_abnormal_humoral_immune | 1.75365288 |
| 14 | MP0002102_abnormal_ear_morphology | 1.73663198 |
| 15 | MP0002876_abnormal_thyroid_physiology | 1.71396837 |
| 16 | MP0004147_increased_porphyrin_level | 1.69828583 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 1.68584669 |
| 18 | MP0008872_abnormal_physiological_respon | 1.66550794 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 1.66235840 |
| 20 | MP0006082_CNS_inflammation | 1.65455909 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.63499670 |
| 22 | MP0000685_abnormal_immune_system | 1.63305190 |
| 23 | MP0000372_irregular_coat_pigmentation | 1.63029363 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 1.60570434 |
| 25 | MP0002160_abnormal_reproductive_system | 1.57370132 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.56797007 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.55160130 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.53706763 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.50654070 |
| 30 | MP0008058_abnormal_DNA_repair | 1.50274278 |
| 31 | MP0001905_abnormal_dopamine_level | 1.50212623 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.49439096 |
| 33 | MP0002723_abnormal_immune_serum | 1.48438897 |
| 34 | MP0001819_abnormal_immune_cell | 1.46372516 |
| 35 | MP0005389_reproductive_system_phenotype | 1.44038947 |
| 36 | MP0002736_abnormal_nociception_after | 1.43337500 |
| 37 | MP0003866_abnormal_defecation | 1.40349659 |
| 38 | MP0008789_abnormal_olfactory_epithelium | 1.40325235 |
| 39 | MP0002234_abnormal_pharynx_morphology | 1.39064157 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.38350594 |
| 41 | MP0008877_abnormal_DNA_methylation | 1.38028930 |
| 42 | MP0005025_abnormal_response_to | 1.37912880 |
| 43 | MP0003878_abnormal_ear_physiology | 1.37384159 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.37384159 |
| 45 | MP0005387_immune_system_phenotype | 1.37024345 |
| 46 | MP0001790_abnormal_immune_system | 1.37024345 |
| 47 | MP0002095_abnormal_skin_pigmentation | 1.35487182 |
| 48 | MP0004885_abnormal_endolymph | 1.35323169 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 1.34267242 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.32393879 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.28832077 |
| 52 | MP0002277_abnormal_respiratory_mucosa | 1.27706158 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.27675264 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.26929887 |
| 55 | MP0002006_tumorigenesis | 1.24848007 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.23858826 |
| 57 | MP0001919_abnormal_reproductive_system | 1.22168608 |
| 58 | MP0005379_endocrine/exocrine_gland_phen | 1.19541520 |
| 59 | MP0004142_abnormal_muscle_tone | 1.16997866 |
| 60 | MP0000716_abnormal_immune_system | 1.16707067 |
| 61 | MP0002398_abnormal_bone_marrow | 1.14363441 |
| 62 | MP0002933_joint_inflammation | 1.13991188 |
| 63 | MP0003786_premature_aging | 1.12805193 |
| 64 | MP0003787_abnormal_imprinting | 1.10055474 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.08747553 |
| 66 | MP0002405_respiratory_system_inflammati | 1.06190741 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.06150361 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 1.02970599 |
| 69 | MP0002653_abnormal_ependyma_morphology | 0.99667996 |
| 70 | MP0000703_abnormal_thymus_morphology | 0.99636207 |
| 71 | MP0008995_early_reproductive_senescence | 0.99227311 |
| 72 | MP0009764_decreased_sensitivity_to | 0.95250570 |
| 73 | MP0005410_abnormal_fertilization | 0.94383410 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 0.93056759 |
| 75 | MP0002722_abnormal_immune_system | 0.92897941 |
| 76 | MP0010155_abnormal_intestine_physiology | 0.91766234 |
| 77 | MP0005253_abnormal_eye_physiology | 0.89254055 |
| 78 | MP0001764_abnormal_homeostasis | 0.89033637 |
| 79 | MP0002429_abnormal_blood_cell | 0.88773086 |
| 80 | MP0003011_delayed_dark_adaptation | 0.87607123 |
| 81 | MP0002272_abnormal_nervous_system | 0.86001454 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 0.85548532 |
| 83 | MP0001485_abnormal_pinna_reflex | 0.83867198 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.83543040 |
| 85 | MP0001663_abnormal_digestive_system | 0.82099986 |
| 86 | MP0001845_abnormal_inflammatory_respons | 0.80963901 |
| 87 | MP0001970_abnormal_pain_threshold | 0.80302692 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.79808095 |
| 89 | MP0003252_abnormal_bile_duct | 0.78442988 |
| 90 | MP0003879_abnormal_hair_cell | 0.78193821 |
| 91 | MP0002132_abnormal_respiratory_system | 0.77678203 |
| 92 | MP0005499_abnormal_olfactory_system | 0.77583689 |
| 93 | MP0005394_taste/olfaction_phenotype | 0.77583689 |
| 94 | MP0003121_genomic_imprinting | 0.77006224 |
| 95 | MP0005174_abnormal_tail_pigmentation | 0.73839685 |
| 96 | MP0002822_catalepsy | 0.73198849 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.72534596 |
| 98 | MP0001293_anophthalmia | 0.72337222 |
| 99 | MP0005085_abnormal_gallbladder_physiolo | 0.71105858 |
| 100 | MP0002419_abnormal_innate_immunity | 0.70463983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.81814257 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.50107901 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.46324370 |
| 4 | 3-Methylglutaconic aciduria (HP:0003535) | 4.08874858 |
| 5 | Acute encephalopathy (HP:0006846) | 4.01113500 |
| 6 | Progressive macrocephaly (HP:0004481) | 3.98777126 |
| 7 | Increased hepatocellular lipid droplets (HP:0006565) | 3.94796127 |
| 8 | Increased CSF lactate (HP:0002490) | 3.88133967 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.87250504 |
| 10 | Aplastic anemia (HP:0001915) | 3.83615018 |
| 11 | Congenital stationary night blindness (HP:0007642) | 3.59954617 |
| 12 | Hepatocellular necrosis (HP:0001404) | 3.58490101 |
| 13 | Increased intramyocellular lipid droplets (HP:0012240) | 3.55010819 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.50098733 |
| 15 | Renal Fanconi syndrome (HP:0001994) | 3.43880656 |
| 16 | Severe combined immunodeficiency (HP:0004430) | 3.38145064 |
| 17 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.24361004 |
| 18 | Constricted visual fields (HP:0001133) | 3.21995318 |
| 19 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.20162158 |
| 20 | Hepatic necrosis (HP:0002605) | 3.17620362 |
| 21 | Cerebral edema (HP:0002181) | 3.16791948 |
| 22 | Reticulocytopenia (HP:0001896) | 3.09486539 |
| 23 | Attenuation of retinal blood vessels (HP:0007843) | 3.04573487 |
| 24 | Optic disc pallor (HP:0000543) | 3.04112156 |
| 25 | Abnormality of B cell number (HP:0010975) | 3.04054690 |
| 26 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.97354842 |
| 27 | Increased muscle lipid content (HP:0009058) | 2.88606715 |
| 28 | Hypoproteinemia (HP:0003075) | 2.86148485 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 2.81761158 |
| 30 | IgG deficiency (HP:0004315) | 2.73741458 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 2.71583514 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 2.71583514 |
| 33 | Pancreatic cysts (HP:0001737) | 2.67469903 |
| 34 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.67295726 |
| 35 | B lymphocytopenia (HP:0010976) | 2.65700830 |
| 36 | Abnormal number of erythroid precursors (HP:0012131) | 2.65502132 |
| 37 | Macrocytic anemia (HP:0001972) | 2.63666749 |
| 38 | Methylmalonic acidemia (HP:0002912) | 2.61488158 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.61118978 |
| 40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.61118978 |
| 41 | Thyroiditis (HP:0100646) | 2.58615388 |
| 42 | Exertional dyspnea (HP:0002875) | 2.54194729 |
| 43 | Increased serum lactate (HP:0002151) | 2.51867853 |
| 44 | Lactic acidosis (HP:0003128) | 2.49139885 |
| 45 | Combined immunodeficiency (HP:0005387) | 2.47086202 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.44936278 |
| 47 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.43530130 |
| 48 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.37724813 |
| 49 | T lymphocytopenia (HP:0005403) | 2.34248667 |
| 50 | Abolished electroretinogram (ERG) (HP:0000550) | 2.33438558 |
| 51 | Abnormality of the prostate (HP:0008775) | 2.33412702 |
| 52 | Congenital, generalized hypertrichosis (HP:0004540) | 2.26823178 |
| 53 | Pancreatic fibrosis (HP:0100732) | 2.26389661 |
| 54 | Absent/shortened dynein arms (HP:0200106) | 2.26238733 |
| 55 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.26238733 |
| 56 | Type I transferrin isoform profile (HP:0003642) | 2.20706159 |
| 57 | Hyperglycinemia (HP:0002154) | 2.20258339 |
| 58 | True hermaphroditism (HP:0010459) | 2.20001552 |
| 59 | Lethargy (HP:0001254) | 2.17542663 |
| 60 | Abnormality of eosinophils (HP:0001879) | 2.17482267 |
| 61 | Abnormality of macular pigmentation (HP:0008002) | 2.16225973 |
| 62 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.15162962 |
| 63 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.15162962 |
| 64 | Eosinophilia (HP:0001880) | 2.14041864 |
| 65 | Exercise intolerance (HP:0003546) | 2.13664786 |
| 66 | Colon cancer (HP:0003003) | 2.13324792 |
| 67 | Respiratory failure (HP:0002878) | 2.13003607 |
| 68 | Pallor (HP:0000980) | 2.11809661 |
| 69 | Panhypogammaglobulinemia (HP:0003139) | 2.11634522 |
| 70 | Abnormality of renal resorption (HP:0011038) | 2.10564526 |
| 71 | Pancytopenia (HP:0001876) | 2.09612501 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 2.08945457 |
| 73 | Abnormality of T cells (HP:0002843) | 2.05666788 |
| 74 | Abnormal protein glycosylation (HP:0012346) | 2.03781603 |
| 75 | Abnormal glycosylation (HP:0012345) | 2.03781603 |
| 76 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.03781603 |
| 77 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.03781603 |
| 78 | Methylmalonic aciduria (HP:0012120) | 1.99710378 |
| 79 | Leukodystrophy (HP:0002415) | 1.95773017 |
| 80 | Stomatitis (HP:0010280) | 1.94676694 |
| 81 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.93612650 |
| 82 | Respiratory difficulties (HP:0002880) | 1.92642362 |
| 83 | Increased IgM level (HP:0003496) | 1.91873027 |
| 84 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.90762676 |
| 85 | Type 2 muscle fiber atrophy (HP:0003554) | 1.90565320 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 1.90421432 |
| 87 | Glycosuria (HP:0003076) | 1.90421432 |
| 88 | Absent thumb (HP:0009777) | 1.88406780 |
| 89 | Asplenia (HP:0001746) | 1.84227477 |
| 90 | Hyperphosphaturia (HP:0003109) | 1.83786531 |
| 91 | Type II lissencephaly (HP:0007260) | 1.83610315 |
| 92 | Pendular nystagmus (HP:0012043) | 1.82931682 |
| 93 | Ketosis (HP:0001946) | 1.82904077 |
| 94 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.82873809 |
| 95 | Cerebral palsy (HP:0100021) | 1.80556396 |
| 96 | Abnormal ciliary motility (HP:0012262) | 1.79310908 |
| 97 | Decreased central vision (HP:0007663) | 1.76554229 |
| 98 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.73936044 |
| 99 | Emotional lability (HP:0000712) | 1.71774406 |
| 100 | Prostate neoplasm (HP:0100787) | 1.71368117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.02577040 |
| 2 | TESK2 | 3.85311093 |
| 3 | TXK | 3.64289377 |
| 4 | BCKDK | 3.60263623 |
| 5 | MAP4K2 | 3.04289777 |
| 6 | ZAK | 2.85134247 |
| 7 | VRK2 | 2.82547423 |
| 8 | KIT | 2.34273950 |
| 9 | TLK1 | 2.28969295 |
| 10 | STK16 | 2.26726953 |
| 11 | TAOK3 | 2.26451776 |
| 12 | ADRBK2 | 2.12421777 |
| 13 | MAP4K1 | 2.10529899 |
| 14 | GRK1 | 2.03860630 |
| 15 | FES | 2.03184509 |
| 16 | TEC | 1.94581688 |
| 17 | MAP3K12 | 1.89666952 |
| 18 | SCYL2 | 1.87587570 |
| 19 | CDK19 | 1.86550055 |
| 20 | LIMK1 | 1.80009948 |
| 21 | VRK1 | 1.70914967 |
| 22 | PINK1 | 1.59153104 |
| 23 | TIE1 | 1.57327466 |
| 24 | ITK | 1.51802022 |
| 25 | NUAK1 | 1.43701184 |
| 26 | WNK4 | 1.41386044 |
| 27 | SYK | 1.38056807 |
| 28 | FRK | 1.36807698 |
| 29 | PASK | 1.35793740 |
| 30 | NME2 | 1.34382011 |
| 31 | CAMKK2 | 1.14580031 |
| 32 | PRKCQ | 1.11910771 |
| 33 | IKBKB | 1.11874185 |
| 34 | MUSK | 1.11786429 |
| 35 | TESK1 | 1.08791437 |
| 36 | BTK | 1.06079701 |
| 37 | MAP3K11 | 1.00595303 |
| 38 | LCK | 0.97877146 |
| 39 | PIM2 | 0.90926617 |
| 40 | DYRK2 | 0.79959641 |
| 41 | BUB1 | 0.78780508 |
| 42 | MAPKAPK3 | 0.78678547 |
| 43 | RPS6KA5 | 0.77999441 |
| 44 | LYN | 0.76486201 |
| 45 | CSK | 0.75251924 |
| 46 | TNK2 | 0.75222053 |
| 47 | DAPK1 | 0.73825479 |
| 48 | CAMKK1 | 0.71139933 |
| 49 | INSRR | 0.69904863 |
| 50 | PIK3CA | 0.69652473 |
| 51 | ADRBK1 | 0.69321574 |
| 52 | GRK6 | 0.68891891 |
| 53 | MAP2K7 | 0.67508373 |
| 54 | EIF2AK3 | 0.66806033 |
| 55 | PIK3CG | 0.66478620 |
| 56 | MAPKAPK5 | 0.66092431 |
| 57 | AURKA | 0.65905377 |
| 58 | GRK7 | 0.64317916 |
| 59 | MST4 | 0.61493123 |
| 60 | MYLK | 0.61236451 |
| 61 | CSF1R | 0.60698470 |
| 62 | WNK3 | 0.60583552 |
| 63 | OBSCN | 0.59017210 |
| 64 | PLK4 | 0.58155527 |
| 65 | TAF1 | 0.54942706 |
| 66 | NME1 | 0.54499191 |
| 67 | IKBKE | 0.52521247 |
| 68 | DAPK3 | 0.51798714 |
| 69 | CSNK1G3 | 0.51690704 |
| 70 | OXSR1 | 0.51229571 |
| 71 | LRRK2 | 0.49803230 |
| 72 | PIM1 | 0.49252328 |
| 73 | ABL2 | 0.47595393 |
| 74 | TYRO3 | 0.46515044 |
| 75 | PRKACA | 0.46207793 |
| 76 | BMPR1B | 0.43063137 |
| 77 | MAPK13 | 0.42751999 |
| 78 | PRKCA | 0.41958537 |
| 79 | CSNK2A2 | 0.41706801 |
| 80 | CSNK2A1 | 0.41690130 |
| 81 | STK39 | 0.40842265 |
| 82 | MAP2K6 | 0.40811515 |
| 83 | MAP3K5 | 0.39514058 |
| 84 | RPS6KB2 | 0.38915723 |
| 85 | CSNK1G2 | 0.38164565 |
| 86 | PRKCI | 0.36115771 |
| 87 | MATK | 0.36064086 |
| 88 | IGF1R | 0.34865005 |
| 89 | GRK5 | 0.34554192 |
| 90 | INSR | 0.32567253 |
| 91 | DAPK2 | 0.32373480 |
| 92 | CSNK1A1 | 0.32353394 |
| 93 | PRKCG | 0.31807658 |
| 94 | RPS6KA4 | 0.31649791 |
| 95 | ZAP70 | 0.31647576 |
| 96 | CSNK1G1 | 0.30966840 |
| 97 | CAMK1 | 0.30086175 |
| 98 | CSNK1A1L | 0.29354398 |
| 99 | AURKB | 0.29028422 |
| 100 | EIF2AK1 | 0.28823772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.83024386 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.22808289 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.66566396 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.40075592 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.32286597 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.62399361 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.40723664 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.37135646 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.34430287 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.31856627 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.23029132 |
| 12 | RNA polymerase_Homo sapiens_hsa03020 | 2.18470279 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.16266442 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01969142 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99955149 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.99071358 |
| 17 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.87020685 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.83312156 |
| 19 | Phototransduction_Homo sapiens_hsa04744 | 1.82837305 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74774770 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.55258788 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47423635 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46969993 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37208187 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.34689828 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31002721 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.26212502 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.25876408 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.19872049 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.19595562 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.16338699 |
| 32 | Mismatch repair_Homo sapiens_hsa03430 | 1.13564846 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.09880125 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.08970643 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07058123 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.04326844 |
| 37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.02379436 |
| 38 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99062856 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96522142 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95985873 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94258274 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89910886 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 0.89245405 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.87460673 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87028098 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86893784 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86256815 |
| 48 | Base excision repair_Homo sapiens_hsa03410 | 0.86105379 |
| 49 | Basal transcription factors_Homo sapiens_hsa03022 | 0.85607061 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83364768 |
| 51 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.82630374 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82475093 |
| 53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82341063 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81920337 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.79977715 |
| 56 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78168714 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74207739 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74104919 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70692467 |
| 60 | Spliceosome_Homo sapiens_hsa03040 | 0.69645986 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66243539 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64572593 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.61568477 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61208262 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59208893 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57687693 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55978701 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54824905 |
| 69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52192984 |
| 70 | Malaria_Homo sapiens_hsa05144 | 0.49064268 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48111083 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46538368 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45035841 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44873715 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44533196 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44488917 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43528391 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43004838 |
| 79 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.42297836 |
| 80 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41658608 |
| 81 | RNA transport_Homo sapiens_hsa03013 | 0.39315615 |
| 82 | Measles_Homo sapiens_hsa05162 | 0.37606430 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37545449 |
| 84 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.37032437 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.35449246 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35292520 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32199514 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.30536292 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30462412 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.29838694 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26281968 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.25654027 |
| 93 | Taste transduction_Homo sapiens_hsa04742 | 0.24975410 |
| 94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.23961651 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.22891679 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.22365541 |
| 97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.20439808 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.16928897 |
| 99 | Leishmaniasis_Homo sapiens_hsa05140 | 0.16220660 |
| 100 | Morphine addiction_Homo sapiens_hsa05032 | 0.15346702 |

